We are live on ! Find out more
CME icon

CME Group

942 hedge funds and large institutions have $50.5B invested in CME Group in 2018 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 350 increasing their positions, 338 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 62

11% more funds holding in top 10

Funds holding in top 10: 4752 (+5)

7% more capital invested

Capital invested by funds: $47.2B → $50.5B (+$3.34B)

1.77% more ownership

Funds ownership: 85.05%86.82% (+1.8%)

4% more repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 338

1% more funds holding

Funds holding: 933942 (+9)

6% less call options, than puts

Call options by funds: $214M | Put options by funds: $227M

Holders
942
Holders Change
+9
Holders Change %
+0.96%
% of All Funds
21.54%
Holding in Top 10
52
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+10.64%
% of All Funds
1.19%
New
79
Increased
350
Reduced
338
Closed
62
Calls
$214M
Puts
$227M
Net Calls
-$12.9M
Net Calls Change
+$8.91M
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
176
D.E. Shaw & Co
New York
$25.7M -$17M -100,699 -40%
BCIM
177
British Columbia Investment Management
British Columbia, Canada
$25.6M -$5.26M -31,257 -17%
AIG
178
American International Group
New York
$25.1M +$1.21M +7,200 +5%
SLAM
179
Swiss Life Asset Management
$24.9M +$4.93M +29,286 +25%
CIS
180
Capital International Sarl
California
$24.1M -$1.75M -10,400 -7%
CIM
181
Corda Investment Management
Texas
$23.6M -$354K -2,104 -1%
DILIC
182
Dai-ichi Life Insurance Company
Japan
$23.1M -$2.52M -14,983 -10%
Royal London Asset Management
183
Royal London Asset Management
United Kingdom
$23.1M -$870K -5,169 -4%
MG
184
Markel Group
Virginia
$23M
TU
185
TDAM USA
Ontario, Canada
$22.8M +$38.2K +227 +0.2%
WBC
186
Westpac Banking Corp
Australia
$22.7M +$4.29M +25,500 +24%
Man Group
187
Man Group
United Kingdom
$22.4M -$4.86M -28,847 -18%
SCM
188
Sandler Capital Management
New York
$22.4M +$16.2M +96,333 +274%
NA
189
Neuburgh Advisers
California
$22.4M +$520K +3,088 +2%
RIG
190
Roosevelt Investment Group
New York
$22.2M -$252K -1,497 -1%
Fifth Third Bancorp
191
Fifth Third Bancorp
Ohio
$21.5M -$4.92M -29,200 -19%
Nordea Investment Management
192
Nordea Investment Management
Sweden
$21.3M +$1.27M +7,557 +6%
PHS
193
PFM Health Sciences
California
$21.3M -$6.23K -37 -0%
Nisa Investment Advisors
194
Nisa Investment Advisors
Missouri
$20.9M +$2.45M +14,534 +13%
PGF
195
Pelham Global Financials
United Kingdom
$20.7M +$14.1M +83,600 +220%
FA
196
Friess Associates
Delaware
$20.5M
BSA
197
Braun Stacey Associates
New York
$20.4M -$219K -1,298 -1%
RMDI
198
R.M. Davis Inc
Maine
$20.1M +$1.14M +6,745 +6%
VOYA Investment Management
199
VOYA Investment Management
Georgia
$19.8M -$465K -2,765 -2%
Baird Financial Group
200
Baird Financial Group
Wisconsin
$19.5M +$344K +2,043 +2%

CME Hedge Fund Activity: Q3 2018 in Review

942 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in CME Group (CME) for Q3 2018, worth a combined $50.5B — up 7.1% from $47.2B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new CME positions and 62 closed out — a net gain of 17 holders — while 350 added to existing stakes and 338 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $953M. The largest seller was Capital World Investors, cutting an estimated $410M.

  • 942 institutional investors held CME Group (CME) as of Q3 2018, up from 933 in Q2 2018.
  • Funds reported $50.5B of CME Group stock for Q3 2018, up 7.1% quarter-over-quarter.
  • 79 funds opened new CME Group positions in Q3 2018 and 62 closed out, a net change of +17 holders.
  • The largest CME Group buyer in Q3 2018 was Capital Research Global Investors, an estimated $953M added.
  • The largest CME Group seller in Q3 2018 was Capital World Investors, an estimated $410M sold.

Based on aggregated 13F filings for Q3 2018.